Pharma/Biotech – USA, Europe, Asia and ROW Regulatory News – Oct 2024
USA
FDA approves neoadjuvant/adjuvant nivolumab for resectable non-small cell lung cancer
The Food and Drug Administration approved nivolumab (Opdivo, Bristol Myers Squibb Company) with platinum-doublet...
Approval Healthcare Updates, Biotech News, Cancer Treatment, Drug Approval, FDA, Medical Advancements, Medicines, Patient Care, Pharma News, Regulatory News